Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
-supported research infrastructure. Our group develops computational and statistical methods for large-scale genomic, clinical, and phenotypic data and collaborates closely with partners in computer science
-
understand cancer biology, identify diagnostic and prognostic biomarkers, and improve cancer therapy. Projects will involve the development of AI solutions, particularly by leveraging large language and vision
-
analysing large and complex datasets, including multi-omics and perturbation-response data, with a strong emphasis on data quality, reproducibility, and biological interpretability. Practical experience in
-
worldwide to explore postdoctoral opportunities at leading science and technology institutions in Korea. Launched by the Korean government, the InnoCORE program is a large-scale national initiative designed
-
catalysts for C–H activation, or Development of quantum chemical methods for transition metal systems, with a particular focus on methods for large, complex systems (proteins, enzymes, and condensed phases
-
or Functional ultrasound imaging or Electrophysiology (neuropixels) in behaving animals Quantitative data analysis and computational modeling of network activity Data acquisition systems, signal processing and
-
biostatistical methods to better personalize treatment of cancer patients from deep and diverse types of biomedical information. Analysis of large‑scale clinical, genomic, and molecular datasets. Development and
-
scientific discovery with a focus on microscopy image analysis. Specifically, we are interested in the development of new methods to identify structures of interest in large datasets (detection, segmentation
-
, fluorescence lifetime and vibrational imaging methods. Large-scale and high-throughput imaging and analysis pipelines: data acquisition and analysis to characterize cell-types and connectivity in mammalian brain
-
researchers. The group conducts large-scale registry-based research covering all aspects of drug utilization, effectiveness, and safety, using Danish nationwide health registries as well as international data